Semaglutide and Intermittent Fasting: Maximize Fat Burn
Integrating Semaglutide with Intermittent Fasting: A Paradigm Shift in Metabolic Optimization The intersection of pharmacotherapy and nutritional timing has ushered in a new era in obesity management. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been clinically validated to significantly reduce body weight by modulating appetite and enhancing satiety. When combined with intermittent fasting (IF), … Read more